Thank you, Michael, and thanks everyone for joining us today. On a consolidated basis, our fourth-quarter revenues were down 1% relative to the prior year period, completing what was again as anticipated a back-half weighted year for Superior Group of Companies, Inc. and placing us within our outlook range. I want to again emphasize that we expect a similar pattern for 2025. Looking closer at top-line performance starting with branded products, revenue was off 5% year over year. Sales of promotional products grew, while branded uniform sales with existing customers were down year over year primarily due to stronger uniform program rollouts in the year-ago quarter. We grew healthcare revenue 8% over the prior year, primarily driven by growth in our digital channels, as well as some favorable sales timing in our non-digital channels. And for contact centers, we drove 4% top-line growth. We now have a sales force in place, as Michael just mentioned, and while we saw a decline from existing customers, this was offset by an even stronger contribution from new customers that also provide the opportunity for future seat expansion. Turning to margins and profitability, our consolidated gross margin for the fourth quarter of 37.1% was down just 70 basis points relative to the year-earlier quarter despite the tough comparison. And SG&A as a percent of revenues at 34.4% was about a percentage point higher. This resulted in consolidated EBITDA of $7.3 million versus $9.9 million in the fourth quarter of 2023. On a segment-by-segment basis, branded products' fourth-quarter gross margin was down a percentage point to 33.9%, driven by sourcing mix and lower volume related to our branded uniform programs. As we have said in the past, the sales and margin mix of uniformed programs can vary on a quarterly basis depending upon the timing of program rollouts and sourcing consideration. SG&A as a percent of revenues for the fourth quarter increased about a percentage point to 25.9%, mainly driven by deleveraging. As a result, branded products EBITDA was $8.9 million for the quarter, down from $11.7 million the prior year. Turning to healthcare apparel, while our fourth-quarter gross margin of 33.7% was off three percentage points due to higher sourcing costs related to manufacturing in Haiti, we did achieve better leverage on SG&A as a percent of revenues by more than a full percentage point on the 8% sales increase. As a result, our healthcare apparel EBITDA came in at $1.1 million relative to $1.4 million in the year-earlier period. For contact centers, which is our highest margin segment, we drove a stronger fourth-quarter gross margin of 54.7%, up more than two and a half percentage points from last year. SG&A as a percentage of revenues at 44.9% improved slightly from 45.1% in the year-ago quarter. This resulted in EBITDA of just over $3 million, up from $2.3 million in the year-ago period. Our fourth-quarter interest expense was $1.5 million, which improved sequentially and also marks a significant improvement from $2.1 million. This improvement was driven by lower weighted average debt outstanding, as I'll discuss in a moment, and a more favorable weighted average interest rate, down 130 basis points over the past year. Our fourth-quarter net income reflecting the EBITDA trends already discussed was $2.1 million relative to $3.6 million in the very strong fourth quarter of 2023. And we generated earnings per diluted share of $0.13 relative to $0.22. Our balance sheet has continued to strengthen with year-end cash and cash equivalents of $19 million at year-end, compared to $20 million at the end of 2023, despite completing more than $7 million of share repurchases during the year as well as a small acquisition completed during the fourth quarter. We also reduced our outstanding debt to $86 million at year-end, improved from $93 million a year earlier. For the year, we produced strong operating cash flow of $33 million, supporting our net leverage ratio, which ended 2024 at just 1.7 times trailing twelve months covenant EBITDA, improving from 2 times at the start of the year. Providing an update on our share repurchase plan, energized last August, during the fourth quarter, we repurchased approximately 72,000 shares for $1.1 million at an average price of $14.96 per share. We ended the year with approximately $2.6 million remaining under our initial authorization. Today, we are announcing that our board has authorized an additional $17.5 million share repurchase plan with no program expiration. We intend to continue buying back shares depending upon a number of market factors. Support of the new repurchase program and reflecting our improved financial profile, our bank syndicate agreed to amend our credit agreement to increase the annual amount of permitted payments for shareholder distributions, share repurchases, and the like. I'll wrap up with our initial outlook for 2025. As Michael mentioned in prior calls and spoke of in his opening remarks, there are lingering factors resulting in customer hesitancy and overall economic uncertainty. Taking these factors into consideration, we look for full-year revenues to be in the range of $585 million to $595 million, suggesting year-over-year growth at the high end of 5%. We look for full-year earnings per diluted share to be in the range of $0.75 to $0.82, suggesting 12% year-over-year growth at the high end. As mentioned earlier, we expect a back-end weighted cadence to 2025 and similar to what we have achieved in each of the past two years. And with that, operator, if you could please open the line, Michael and I will be happy to take questions.